3 ms·
Pill for Obesity Has Wall Street Salivating
- ryzvonusef 3y ago> For now, Novo Nordisk’s Ozempic and its sister drug, Wegovy, as well as Eli Lilly’s Mounjaro (which is approved for diabetes but not yet for obesity) are expensive—costing over $10,000 a year—and are only available as injections. > In a mid-stage study, the highest dose of an Eli Lilly experimental pill, orforglipron, led to 14.7% weight loss at week 36, according to data published in the New England Journal of Medicine on Friday. Last month, Novo Nordisk, which makes the medication semaglutide under the brand names Ozempic and Wegovy, said that a pill form of that drug helped adults in a trial lose an average 15.1% of their body weight over 68 weeks in a late-stage study. The results were comparable to once-weekly Wegovy injections. > Meanwhile, Pfizer has been testing two oral drugs and on Monday it announced it would move forward with one of them, danuglipron. Analysts called the announcement a setback because the pill is taken twice daily, but Pfizer wrote that it is developing a once-daily modified release version as well.
- EA-3167 3y agoIn about 5-10 I suspect the West in general is going to be slimming down in a pretty big way. The number of people willing to take a weekly injection is already pretty high, but if it's just a pill... people will be lining up for it.